dm+d
420261000
Refrigerated Storage
MenveoGSK
In the event of an inadvertent temperature excursion the following data may be used:
The vaccine components are stable at temperatures up to 25°C for a cumulative time of 120 hours.
Temperature excursions from 0°C to 2°C do not impact the quality of the product.
The product can be returned to the fridge and no change in expiry dates is required if exposed to the above conditions.
Contact GSK in cases where additional stability data is required. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.
Public Health England has guidance on responding to errors in vaccine storage, handling and administration.
NimenrixPfizer
In the event of an inadvertent temperature excursion the following data may be used:
In-house stability data shows the product is stable when stored in the following conditions:
- 25ºC ± 2ºC for 193 days
- 2-8°C for 11 months followed by 1 month storage at 37°C, followed by 24 months storage at 2-8°C
- 40ºC ± 2ºC for 1 month
- Three cycles of 5 days at 25ºC ± 2ºC and 2 days at 5ºC ± 3ºC, followed by long-term storage at 5ºC ± 3ºC for 36 months
- 1 month at 25ºC ± 2ºC followed by long-term storage at 5ºC ± 3ºC for 36 months.
Public Health England has guidance on responding to errors in vaccine storage, handling and administration.